No Data
No Data
Earnings Preview: ESPR to Report Financial Results Pre-market on May 06
Express News | HC Wainwright & Co. Reiterates Buy on Esperion Therapeutics, Maintains $16 Price Target
Express News | Esperion Therapeutics Inc : BofA Global Research Cuts Price Objective to $1.85 From $2
Press Release: Esperion to Report First Quarter 2025 Financial Results on May 6
Esperion Therapeutics Inc (ESPR) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...
Express News | Esperion Therapeutics Inc Files for Mixed Shelf of up to $400 Mln- SEC Filing
Tonyco : Interesting writeup.
I was long on ESPR for most of last year. Grabbed decent profits, but they ultimately dipped and crashed to pennies. Cut them loose after dilution(iirc).
Their valuation makes no sense to me, simply on sales alone.
I'm just sitting on alerts until they fly.